{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T21:30:40Z","timestamp":1777152640758,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T00:00:00Z","timestamp":1547424000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s12026-019-9065-4","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T07:27:50Z","timestamp":1547450870000},"page":"116-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The relationship between pemphigus and systemic lupus erythematosus: a cross-sectional study, systematic review, and meta-analysis"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9971-9151","authenticated-orcid":false,"given":"Khalaf","family":"Kridin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimma","family":"Laufer-Britva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouhammad","family":"Kridin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doron","family":"Comaneshter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erez","family":"Batat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,14]]},"reference":[{"key":"9065_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000099588","volume":"214","author":"M Malik","year":"2007","unstructured":"Malik M, Ahmed AR. Concurrence of systemic lupus erythematosus and pemphigus: coincidence or correlation? Dermatology. 2007;214:231\u20139.","journal-title":"Dermatology"},{"key":"9065_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/bjd.13433","volume":"172","author":"A Parameswaran","year":"2015","unstructured":"Parameswaran A, Attwood K, Sato R, Seiffert-Sinha K, Sinha AA. Identification of a new disease cluster of pemphigus vulgaris with autoimmune thyroid disease, rheumatoid arthritis and type I diabetes. Br J Dermatol. 2015;172:729\u201338.","journal-title":"Br J Dermatol"},{"key":"9065_CR3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1684\/ejd.2017.3060","volume":"27","author":"Y-W Chiu","year":"2017","unstructured":"Chiu Y-W, Chen Y-D, Hua T-C, Wu C-H, Liu H-N, Chang Y-T. Comorbid autoimmune diseases in patients with pemphigus: a nationwide case-control study in Taiwan. Eur J Dermatol. 2017;27:375\u201381.","journal-title":"Eur J Dermatol"},{"key":"9065_CR4","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/bjd.14463","volume":"174","author":"DY Hsu","year":"2016","unstructured":"Hsu DY, Brieva J, Sinha AA, Langan SM, Silverberg JI. Comorbidities and inpatient mortality for pemphigus in the U.S.A. Br J Dermatol. 2016;174:1290\u20138.","journal-title":"Br J Dermatol"},{"key":"9065_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/08916930400024612","volume":"38","author":"Y Muro","year":"2005","unstructured":"Muro Y. Antinuclear antibodies. Autoimmunity. 2005;38:3\u20139.","journal-title":"Autoimmunity"},{"key":"9065_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/exd.12445","volume":"23","author":"J Pr\u00fc\u00dfmann","year":"2014","unstructured":"Pr\u00fc\u00dfmann J, Pr\u00fc\u00dfmann W, Recke A, Rentzsch K, Juhl D, Henschler R, et al. Co-occurrence of autoantibodies in healthy blood donors. Exp Dermatol. 2014;23:519\u201321.","journal-title":"Exp Dermatol"},{"key":"9065_CR7","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.3389\/fimmu.2017.01992","volume":"8","author":"T Sezin","year":"2018","unstructured":"Sezin T, Vorobyev A, Sadik CD, Zillikens D, Gupta Y, Ludwig RJ. Gene expression analysis reveals novel shared gene signatures and candidate molecular mechanisms between pemphigus and systemic lupus erythematosus in CD4+ T cells. Front Immunol. 2018;8:1992.","journal-title":"Front Immunol"},{"key":"9065_CR8","doi-asserted-by":"publisher","unstructured":"Kridin K, Zelber-Sagi S, Comaneshter D, Cohen AD. Ulcerative colitis associated with pemphigus: a population-based large-scale study. Scand J Gastroenterol. 2017;52(12):1360\u20134. https:\/\/doi.org\/10.1080\/00365521.2017.1380839 .","DOI":"10.1080\/00365521.2017.1380839"},{"key":"9065_CR9","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s12026-017-8950-y","volume":"65","author":"K Kridin","year":"2017","unstructured":"Kridin K, Zelber-Sagi S, Comaneshter D, Cohen AD. Is there an association between pemphigus and hepatitis viruses? A population-based large-scale study. Immunol Res. 2017;65:1083\u20138.","journal-title":"Immunol Res"},{"key":"9065_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/jamadermatol.2017.5799","volume":"154","author":"K Kridin","year":"2018","unstructured":"Kridin K, Zelber-Sagi S, Comaneshter D, Cohen AD. Association between pemphigus and neurologic diseases. JAMA Dermatol. 2018;154:281\u20135.","journal-title":"JAMA Dermatol"},{"key":"9065_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"9065_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/01.ede.0000193605.93416.df","volume":"17","author":"EC Somers","year":"2006","unstructured":"Somers EC, Thomas SL, Smeeth L, Hall AJ. Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology. 2006;17:202\u201317.","journal-title":"Epidemiology"},{"key":"9065_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/08916930500050194","volume":"38","author":"M Szyper-Kravitz","year":"2005","unstructured":"Szyper-Kravitz M, Marai I, Shoenfeld Y. Coexistence of thyroid autoimmunity with other autoimmune diseases: friend or foe? Additional aspects on the mosaic of autoimmunity. Autoimmunity. 2005;38:247\u201355.","journal-title":"Autoimmunity"},{"key":"9065_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJM200108023450506","volume":"345","author":"A Davidson","year":"2001","unstructured":"Davidson A, Diamond B. Autoimmune diseases. New Engl J Med. 2001;345:340\u201350.","journal-title":"New Engl J Med"},{"key":"9065_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/j.1365-4632.2010.04818.x","volume":"50","author":"YA Leshem","year":"2011","unstructured":"Leshem YA, Katzenelson V, Yosipovitch G, David M, Mimouni D. Autoimmune diseases in patients with pemphigus and their first-degree relatives. Int J Dermatol. 2011;50:827\u201331.","journal-title":"Int J Dermatol"},{"key":"9065_CR16","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1080\/00365521.2017.1380839","volume":"52","author":"K Kridin","year":"2017","unstructured":"Kridin K, Zelber-Sagi S, Comaneshter D, Cohen AD. Ulcerative colitis associated with pemphigus: a population-based large-scale study. Scand J Gastroenterol. 2017;52:1360\u20134.","journal-title":"Scand J Gastroenterol"},{"key":"9065_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1136\/ard.59.3.230","volume":"59","author":"JE McDonagh","year":"2000","unstructured":"McDonagh JE, Isenberg DA. Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus. Ann Rheum Dis BMJ Publishing Group. 2000;59:230\u20132.","journal-title":"Ann Rheum Dis BMJ Publishing Group"},{"key":"9065_CR18","first-page":"107","volume":"167","author":"N Ghandi","year":"2012","unstructured":"Ghandi N, Kamyab K, Attar SNG, Ghiasi M, Daneshpazhooh M, Karbakhsh M, et al. Antinuclear antibody in patients with pemphigus vulgaris: a case-control study. Br J Dermatol. 2012;167:107.","journal-title":"Br J Dermatol"},{"key":"9065_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2310\/7750.2008.08001","volume":"13","author":"DA Blondin","year":"2009","unstructured":"Blondin DA, Zhang ZH, Shideler KK, Hou HY, Fritzler MJ, Mydlarski PR. Prvalence of non-organ-specific autoantibodies in patients with pemphigus vulgaris. J Cutan Med Surg. 2009;13:82\u20137.","journal-title":"J Cutan Med Surg"},{"key":"9065_CR20","doi-asserted-by":"publisher","unstructured":"Amber KT, Valdebran M, Grando SA. Non-desmoglein antibodies in patients with pemphigus vulgaris. Front Immunol. 2018;9:1190. https:\/\/doi.org\/10.3389\/fimmu.2018.01190 . eCollection 2018.","DOI":"10.3389\/fimmu.2018.01190"},{"key":"9065_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1177\/0961203310385738","volume":"20","author":"A Ippolito","year":"2011","unstructured":"Ippolito A, Wallace DJ, Gladman D, Fortin PR, Urowitz M, Werth V, et al. Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus. 2011;20:250\u20135.","journal-title":"Lupus"},{"key":"9065_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1523-1747.1998.00107.x","volume":"110","author":"LS Chan","year":"1998","unstructured":"Chan LS, Vanderlugt CJ, Hashimoto T, Nishikawa T, Zone JJ, Black MM, et al. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol. 1998;110:103\u20139.","journal-title":"J Invest Dermatol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-019-9065-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-019-9065-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-019-9065-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T11:48:18Z","timestamp":1606045698000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-019-9065-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,14]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["9065"],"URL":"https:\/\/doi.org\/10.1007\/s12026-019-9065-4","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,14]]},"assertion":[{"value":"14 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Prof. Arnon Cohen received research grants from Janssen, Novartis, AbbVie, Janssen, and Sanofi. Prof. Arnon Cohen served as a consultant, advisor, or speaker to AbbVie, Amgen, Boehringer Ingelheim, Dexcel pharma, Janssen, Kamedis, Lilly, Neopharm, Novartis, Perrigo, Pfizer, Rafa, Samsung Bioepis, Sanofi, Sirbal, and Taro. No funding was gained for the research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}